Comparative Effectiveness of Radiation Versus Radical Cystectomy for Localized Muscle-Invasive Bladder Cancer

2005, Neoadjuvant chemotherapy in invasive bladder cancer: Update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration, Eur Urol, 48, 202, 10.1016/j.eururo.2005.04.006 Grossman, 2003, Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer, N Engl J Med, 349, 859, 10.1056/NEJMoa022148 Griffiths, 2011, International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: Long-term results of the BA06 30894 trial, J Clin Oncol, 29, 2171, 10.1200/JCO.2010.32.3139 2003, Advanced Bladder Cancer Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: A systematic review and meta-analysis, Lancet, 361, 1927, 10.1016/S0140-6736(03)13580-5 Efstathiou, 2012, Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: The MGH experience, Eur Urol, 61, 705, 10.1016/j.eururo.2011.11.010 Krause, 2011, 15-year survival rates after transurethral resection and radiochemotherapy or radiation in bladder cancer treatment, Anticancer Res, 31, 985 Chung, 2007, Long-term outcome of radiation-based conservation therapy for invasive bladder cancer, Urol Oncol, 25, 303, 10.1016/j.urolonc.2006.09.015 Giacalone, 2017, Long-term outcomes after bladder-preserving tri-modality therapy for patients with muscle-invasive bladder cancer: An updated analysis of the Massachusetts General Hospital Experience, Eur Urol, 71, 952, 10.1016/j.eururo.2016.12.020 Rödel, 2002, Combined-modality treatment and selective organ preservation in invasive bladder cancer: Long-term results, J Clin Oncol, 20, 3061, 10.1200/JCO.2002.11.027 Kim, 2017, Comparison of outcomes between trimodal therapy and radical cystectomy in muscle-invasive bladder cancer: A propensity score matching analysis, Oncotarget, 8, 68996, 10.18632/oncotarget.16576 James, 2012, Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer, N Engl J Med, 366, 1477, 10.1056/NEJMoa1106106 European Association of Urology The Muscle-invasive and Metastatic Bladder Cancer Guidelines; 2022. Available at:https://uroweb.org/guideline/bladder-cancer-muscle-invasive-and-metastatic/. Accessed December 2, 2022. Powles, 2022, Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up, Ann Oncol, 33, 244, 10.1016/j.annonc.2021.11.012 NCCN Guidelines, Version 2. 2022 Bladder Cancer, Available at:https://www.nccn.org/professionals/physician_gls/pdf/bladder.pdf. Accessed December 2, 2022. Weiss, 2007, Radiochemotherapy with cisplatin and 5-fluorouracil after transurethral surgery in patients with bladder cancer, Int J Radiat Oncol Biol Phys, 68, 1072, 10.1016/j.ijrobp.2007.01.054 Kulkarni, 2017, Propensity score analysis of radical cystectomy versus bladder-sparing trimodal therapy in the setting of a multidisciplinary bladder cancer clinic, J Clin Oncol, 35, 2299, 10.1200/JCO.2016.69.2327 Seisen, 2017, Comparative effectiveness of trimodal therapy versus radical cystectomy for localized muscle-invasive urothelial carcinoma of the bladder, Eur Urol, 72, 483, 10.1016/j.eururo.2017.03.038 Fahmy, 2018, A systematic review and meta-analysis on the oncological long-term outcomes after trimodality therapy and radical cystectomy with or without neoadjuvant chemotherapy for muscle-invasive bladder cancer, Urol Oncol, 36, 43, 10.1016/j.urolonc.2017.10.002 Morishima, 2019, Impact of comorbidities on survival in gastric, colorectal, and lung cancer patients, J Epidemiol, 29, 110, 10.2188/jea.JE20170241 Nishikawa, 2021, Multicentre cohort study of the impact of percutaneous coronary intervention on patients with concurrent cancer and ischaemic heart disease, BMC Cardiovasc Disord, 21, 177, 10.1186/s12872-021-01968-w Fuji, 2021, Analysis of real-world data in patients with relapsed/refractory diffuse large B cell lymphoma who received salvage chemotherapy in the rituximab era, Ann Hematol, 100, 2253, 10.1007/s00277-020-04342-6 Quan, 2005, Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data, Med Care, 43, 1130, 10.1097/01.mlr.0000182534.19832.83 Quan, 2011, Updating and validating the Charlson Comorbidity Index and score for risk adjustment in hospital discharge abstracts using data from 6 countries, Am J Epidemiol, 173, 676, 10.1093/aje/kwq433 Morishima, 2021, Barthel Index-based functional status as a prognostic factor in young and middle-aged adults with newly diagnosed gastric, colorectal and lung cancer: A multicentre retrospective cohort study, BMJ Open, 11, 10.1136/bmjopen-2020-046681 Austin, 2011, An introduction to propensity score methods for reducing the effects of confounding in observational studies, Multivariate Behav Res, 46, 399, 10.1080/00273171.2011.568786 Leow, 2014, Propensity-matched comparison of morbidity and costs of open and robot-assisted radical cystectomies: A contemporary population-based analysis in the United States, Eur Urol, 66, 569, 10.1016/j.eururo.2014.01.029 Cockerell, 2017, Prevalence of renal angiomyolipomas and spontaneous bleeding related to angiomyolipomas in tuberous sclerosis complex patients in France and Norway—A Questionnaire Study, Urology, 104, 70, 10.1016/j.urology.2017.02.023 Asia Consensus Statements Version 1 [2016]of NCCN Guidelines Version 2. 2015 Bladder Cancer, Available at: https://www.nccn.org/professionals/physician_gls/pdf/bladder-asia.pdf. Accessed December 2, 2022. Parekh, 2018, Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): An open-label, randomised, phase 3, non-inferiority trial, Lancet, 391, 2525, 10.1016/S0140-6736(18)30996-6 Bochner, 2018, Randomized trial comparing open radical cystectomy and robot-assisted laparoscopic radical cystectomy: Oncologic outcomes, Eur Urol, 74, 465, 10.1016/j.eururo.2018.04.030 Hanna, 2018, Comparative effectiveness of robot-assisted vs. open radical cystectomy, Urol Oncol, 36, 10.1016/j.urolonc.2017.09.018